22nd Century Announces 1-for-135 Reverse Stock Split
22nd Century Announces 1-for-135 Reverse Stock Split
Mocksville, North Carolina--(Newsfile Corp. - December 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it will effect a reverse stock split of its outstanding shares of common stock, par value $0.00001 per share (the "Common Stock"), at a ratio of 1-for-135, to be effective as of December 17, 2024. The reverse stock split is intended for the Company to regain compliance with the minimum bid price requirement of $1.00 per share of common stock for continued listing on Nasdaq.
北卡羅來納州莫克斯維爾--(Newsfile Corp.,2024年12月13日)——22世紀集團公司(納斯達克股票代碼:XXII)是一家領導反向尼古丁鬥爭並認爲吸菸者應該對尼古丁消費有選擇權的菸草製品公司,今天宣佈,它將反向拆分面值爲每股0.00001美元的已發行普通股(「普通股」),比例爲 1:135,將於 2024 年 12 月 17 日起生效。反向股票拆分旨在使公司重新遵守繼續在納斯達克上市的普通股每股1.00美元的最低出價要求。
Lawrence Firestone, Chief Executive Officer said, "Over the past year since joining the Company, we have made significant changes which have improved our operating model and balance sheet. We are moving quickly to activate our new VLN strategy which includes deploying private label VLN brands. We are on track to become EBITDA profitable as early as the first quarter of 2025. With our operating improvements and recent actions, we recently regained compliance with the shareholder's equity requirement, and this last step will enable us to regain compliance with the Nasdaq minimum bid price requirement as we continue to work toward creating long-term shareholder value."
首席執行官勞倫斯·費爾斯通表示:「自加入公司以來的過去一年中,我們做出了重大改變,改善了我們的運營模式和資產負債表。我們正在迅速採取行動,啓動新的VLN戰略,其中包括部署自有品牌VLN品牌。我們有望最早在2025年第一季度實現息稅折舊攤銷前利潤盈利。通過我們的經營改善和最近的行動,我們最近恢復了對股東權益要求的遵守,而這最後一步將使我們能夠在繼續努力創造長期股東價值的同時,恢復對納斯達克最低出價要求的遵守。」
22nd Century Common Stock will begin trading on a reverse stock split-adjusted basis at the opening of The Nasdaq Capital Market ("Nasdaq") on Tuesday, December 17, 2024. Following the reverse stock split, the Common Stock will continue to trade on Nasdaq under the symbol "XXII" with the new CUSIP number, 90137F400.
22世紀普通股將於2024年12月17日星期二納斯達克資本市場(「納斯達克」)開盤時開始在股票拆分調整後的反向基礎上交易。股票反向拆分後,普通股將繼續在納斯達克交易,股票代碼爲 「XXII」,新的CUSIP編號爲 90137F400。
The reverse stock split will consolidate the number of issued and outstanding shares of the Company's common stock to approximately 504,000.
反向股票拆分將使公司普通股的已發行和流通股數量合併到約50.4萬股。
About 22nd Century Group, Inc.
關於 22nd Century Group, Inc
22nd Century Group is the pioneering nicotine harm reduction company in the tobacco industry enabling smokers to take control of their nicotine consumption.
22nd Century Group 是菸草行業減少尼古丁危害的先驅公司,使吸菸者能夠控制他們的尼古丁消費。
We created our flagship product, the VLN cigarette, to give traditional cigarette smokers an authentic and familiar alternative that helps them take control of their nicotine consumption. VLN cigarettes have 95% less nicotine than the traditional cigarette and have been proven to greatly reduce nicotine consumption. Instead of offering new ways of delivering nicotine to addicted smokers, we offer smokers the option to take control of their nicotine consumption and make informed and more productive choices, including the choice to avoid addictive levels of nicotine altogether.
我們開發了我們的旗艦產品VLN香菸,旨在爲傳統吸菸者提供一種真實而熟悉的替代品,幫助他們控制尼古丁的消費。VLN香菸的尼古丁含量比傳統香菸低95%,並且已被證明可以大大減少尼古丁的消費。我們沒有提供向成癮的吸菸者提供尼古丁的新方法,而是爲吸菸者提供控制尼古丁消費,做出明智和更有成效的選擇,包括選擇完全避免尼古丁成癮水平。
Our wholly owned subsidiaries include a leading cigarette manufacturer that produces all VLN products and provides turnkey contract manufacturing for other tobacco brands both domestically and internationally. The 60,000 square foot facility in Mocksville, North Carolina has the capacity to produce more than 45 million cartons of combusted tobacco products annually with additional space for expansion.
我們的全資子公司包括一家領先的捲菸製造商,該公司生產所有VLN產品,併爲國內和國際上的其他菸草品牌提供一站式合同製造。這座位於北卡羅來納州莫克斯維爾的佔地60,000平方英尺的工廠每年可生產超過4500萬箱的燃燒菸草製品,還有額外的擴建空間。
Our proprietary reduced nicotine tobacco blends are made possible by comprehensive and patented technologies that regulate nicotine biosynthesis activities in the tobacco plant, resulting in full flavor and high yield with 95% less nicotine. Our extensive patent portfolio has been developed to ensure we have the only low nicotine combustible cigarette in the United States and critical international markets. Our mission is to sell the last cigarette before the 22nd Century.
我們的專利技術使我們專有的還原尼古丁菸草混合物成爲可能,這些技術可調節菸草植物中的尼古丁生物合成活動,從而在尼古丁減少95%的情況下獲得飽滿的風味和高產量。我們開發了廣泛的專利組合,以確保我們擁有美國和關鍵國際市場上唯一的低尼古丁可燃香菸。我們的使命是賣出22世紀之前的最後一支香菸。
VLN and Helps You Smoke Less are registered trademarks of 22nd Century Limited LLC.
VLN 和 Helps You Smoke Less 是 22 世紀有限責任公司的註冊商標。
Learn more at xxiicentury.com, on X (formerly Twitter), on LinkedIn, and on YouTube.
要了解更多,請訪問 xxiicentury.com,開啓 X(前身爲 Twitter),開啓 領英,等等 優酷.
Learn more about VLN at tryvln.com.
要了解有關 VLN 的更多信息,請訪問 tryvln.com.
Cautionary Note Regarding Forward-Looking Statements
關於前瞻性陳述的警示說明
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as "anticipate," "believe," "consider," "continue," "could," "estimate," "expect," "explore," "foresee," "goal," "guidance," "intend," "likely," "may," "plan," "potential," "predict," "preliminary," "probable," "project," "promising," "seek," "should," "will," "would," and similar expressions. Forward-looking statements include, but are not limited to, statements regarding (i) our cost reduction initiatives, (ii) our expectations regarding regulatory enforcement, including our ability to receive an exemption from new regulations, (iii) our financial and operating performance and (iv) our expectations for our business interruption insurance claim. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in "Risk Factors" in the Company's Annual Report on Form 10-K filed on March 28, 2024, and in the Company's Quarterly Reports filed on May 15, 2024, August 13, 2024 and November 11, 2024. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.
除歷史信息外,本新聞稿中包含的所有陳述、預期和假設均爲前瞻性陳述,包括但不限於我們的全年業務展望。前瞻性陳述通常包含 「預測」、「相信」、「考慮」、「繼續」、「可能」、「估計」、「預期」、「探索」、「預見」、「目標」、「指導」、「打算」、「可能」、「計劃」、「潛在」、「預測」、「初步」、「可能」、「項目」、「有希望」、「尋求」 等術語、” 「應該」、「將」、「將」 和類似的表達。前瞻性陳述包括但不限於有關以下方面的陳述:(i)我們的成本削減計劃,(ii)我們對監管執法的預期,包括我們獲得新法規豁免的能力,(iii)我們的財務和經營業績以及(iv)我們對業務中斷保險索賠的預期。實際結果可能與前瞻性陳述中的明示或隱含結果存在重大差異。公司於2024年3月28日提交的10-k表年度報告中的 「風險因素」 以及公司於2024年5月15日、2024年8月13日和2024年11月11日提交的季度報告中列出了可能導致實際業績出現重大差異的重要因素。本新聞稿中提供的所有信息均爲截至本新聞稿發佈之日,除非法律要求,否則公司不承擔任何義務也不打算更新這些前瞻性陳述。
Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
mkreps@xxiicentury.com
214-597-8200
投資者關係與媒體聯繫人
馬特·克雷普斯
投資者關係
22 世紀集團
mkreps@xxiicentury.com
214-597-8200